ELIXOPHYLLIN- theophylline anhydrous liquid United States - English - NLM (National Library of Medicine)

elixophyllin- theophylline anhydrous liquid

atlantic biologicals corps - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

ELIXOPHYLLIN- theophylline anhydrous liquid United States - English - NLM (National Library of Medicine)

elixophyllin- theophylline anhydrous liquid

carilion materials management - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir (theophylline oral solution, usp) is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Theophylline Extended-Release Tablets United States - English - NLM (National Library of Medicine)

theophylline extended-release tablets

bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

nostrum laboratories, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE- theophylline tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline- theophylline tablet, extended release

camber pharmaceuticals, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

bionpharma inc., - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release United States - English - NLM (National Library of Medicine)

theophylline tablet, extended release

sun pharmaceutical industries limited - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 100mg - theophylline 100mg - respiratory smooth muscle relaxants

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 200mg - theophylline 200mg - respiratory smooth muscle relaxants

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 300mg - theophylline 300mg - respiratory smooth muscle relaxants